Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
9 pending office actions • 8 clients • 9 examiners • 7 art units • 0 of 9 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days
Feeney IP Law operates in the Biotechnology & Pharmaceuticals technology area. The firm has 172 career applications and a resolved allowance rate pct of 67.9. The avg office actions per allowance for these applications is 3.38. This figure indicates the typical number of office actions the firm navigates during the prosecution of a patent application.
There are 7 pending office actions currently being handled by the firm. These statistics provide a summary of the firm's experience and current activity in biotechnology and pharmaceutical patent prosecution. The resolved allowance rate pct of 67.9 and the 172 career applications offer a data-grounded view of the firm's historical performance in these sectors. The 7 pending office actions represent the firm's current active workload. Practitioners can use the avg office actions per allowance of 3.38 to plan for the expected duration of the examination process.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (22%) |
| Multi-statute (no §101) | 7 (78%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BOECKER, JOSEPH D | 1 | 83.6% | +23.0% |
| HELM, CARALYNNE E | 1 | 28.9% | +49.6% |
| CRUM, MARY ABOU NADER | 1 | 40.4% | +65.0% |
| CHANDRAKUMAR, NIZAL S | 1 | 72.7% | +18.3% |
| BREEN, KIMBERLY CATHERINE | 1 | 23.8% | +56.9% |
| TIEN, LUCY MINYU | 1 | 59.3% | +39.2% |
| BECKHARDT, LYNDSEY MARIE | 1 | 27.8% | +48.0% |
| TRUONG, QUANGLONG N | 1 | 78.8% | +23.6% |
| FELTON, AILEEN BAKER | 1 | 51.9% | +16.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18426299 | SUBCUTANEOUS BIODEGRADABLE NALTREXONE IMPLANT AND ACCOMPANYING BEHAVIORAL PROGRAM FOR WEIGHT LOSS IN A PATIENT | HELM, CARALYNNE E | 105d overdue |
| 18248021 | NANOMATERIAL AND METHODS OF USE THEREOF | BECKHARDT, LYNDSEY MARIE | 56d |
| 18683221 | FACE MASKS AND BAG-VALVE MASK RESUSCITATOR SYSTEMS FOR VENTILATION OF PATIENTS | BOECKER, JOSEPH D | — |
| 18274950 | MATRIX FORMULATED WITH PROBIOTICS FOR USE IN THE TREATMENT OF CARIES | CRUM, MARY ABOU NADER | — |
| 18270682 | Biodegradable Implant Including Naltrexone and Cholesterol | CHANDRAKUMAR, NIZAL S | — |
| 18267990 | METHOD FOR PRODUCING HUMAN COLLAGEN STRUCTURES WITH CONTROLLED CHARACTERISTICS | BREEN, KIMBERLY CATHERINE | — |
| 18053567 | MONOPROPELLANT HYDROGEN PEROXIDE FUEL COMPOSITIONS SUITABLE FOR USE IN NO OXYGEN ENVIRONMENTS | FELTON, AILEEN BAKER | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18426299 | SUBCUTANEOUS BIODEGRADABLE NALTREXONE IMPLANT AND ACCOMPANYING BEHAVIORAL PROGRAM FOR WEIGHT LOSS IN A PATIENT | HELM, CARALYNNE E | 105d overdue |
| 18179863 | TINCTURE CONTAINING CANNABINOIDS, METHOD OF USING, AND METHOD OF MAKING THE SAME | TRUONG, QUANGLONG N | 50d overdue |
| 18331443 | BROAD SPECTRUM CANNABINOID AND TERPENE MINERAL SALVE, METHOD OF USING, AND METHOD OF MAKING THE SAME | TIEN, LUCY MINYU | 24d overdue |
| 18248021 | NANOMATERIAL AND METHODS OF USE THEREOF | BECKHARDT, LYNDSEY MARIE | 56d |
| 18683221 | FACE MASKS AND BAG-VALVE MASK RESUSCITATOR SYSTEMS FOR VENTILATION OF PATIENTS | BOECKER, JOSEPH D | — |
| 18274950 | MATRIX FORMULATED WITH PROBIOTICS FOR USE IN THE TREATMENT OF CARIES | CRUM, MARY ABOU NADER | — |
| 18270682 | Biodegradable Implant Including Naltrexone and Cholesterol | CHANDRAKUMAR, NIZAL S | — |
| 18267990 | METHOD FOR PRODUCING HUMAN COLLAGEN STRUCTURES WITH CONTROLLED CHARACTERISTICS | BREEN, KIMBERLY CATHERINE | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Holistic Hemp | 2 |
| Spirare Medical LLC | 1 |
| Biocorrx | 1 |
| Maria Fernanda De La Rosa Flores | 1 |
| Biocorrx, Inc. | 1 |
| José Adán ORTEGA BLANCO | 1 |
| University of Connecticut | 1 |
| Kenneth Moden | 1 |
| Art Unit | Apps |
|---|---|
| 1615 | 2 |
| 1600 | 1 |
| 1625 | 1 |
| 1657 | 1 |
| 1612 | 1 |
| 1613 | 1 |
| 1734 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18683221 | FACE MASKS AND BAG-VALVE MASK RESUSCITATOR SYSTEMS FOR VENTILATION OF PATIENTS | Spirare Medical LLC | BOECKER, JOSEPH D | §102§103§112 | Non-Final OA | — | Pending | Feb 12, 2024 | |
| 18426299 | SUBCUTANEOUS BIODEGRADABLE NALTREXONE IMPLANT AND ACCOMPANYING BEHAVIORAL PROGRAM FOR WEIGHT LOSS IN A PATIENT | Biocorrx | HELM, CARALYNNE E | 1615 | §103§112 | Non-Final OA | 105d overdue | Pending | Jan 29, 2024 |
| 18274950 | MATRIX FORMULATED WITH PROBIOTICS FOR USE IN THE TREATMENT OF CARIES | Maria Fernanda De La Rosa Flores | CRUM, MARY ABOU NADER | 1600 | §103§112 | Non-Final OA | — | Pending | Jul 28, 2023 |
| 18270682 | Biodegradable Implant Including Naltrexone and Cholesterol | Biocorrx, Inc. | CHANDRAKUMAR, NIZAL S | 1625 | §103§112 | Non-Final OA | — | Pending | Jun 30, 2023 |
| 18267990 | METHOD FOR PRODUCING HUMAN COLLAGEN STRUCTURES WITH CONTROLLED CHARACTERISTICS | José Adán Ortega Blanco | BREEN, KIMBERLY CATHERINE | 1657 | §103§112 | Final Rejection | — | Pending | Jun 16, 2023 |
| 18331443 | BROAD SPECTRUM CANNABINOID AND TERPENE MINERAL SALVE, METHOD OF USING, AND METHOD OF MAKING THE SAME | Holistic Hemp Solutions, Inc. | TIEN, LUCY MINYU | 1612 | §103 | Non-Final OA | 24d overdue | Pending | Jun 08, 2023 |
| 18248021 | NANOMATERIAL AND METHODS OF USE THEREOF | UNIVERSITY OF CONNECTICUT | BECKHARDT, LYNDSEY MARIE | 1613 | §102§103Other | Final Rejection | 56d | Pending | Apr 05, 2023 |
| 18179863 | TINCTURE CONTAINING CANNABINOIDS, METHOD OF USING, AND METHOD OF MAKING THE SAME | Holistic Hemp Solutions, Inc. | TRUONG, QUANGLONG N | 1615 | §103 | Final Rejection | 50d overdue | Pending | Mar 07, 2023 |
| 18053567 | MONOPROPELLANT HYDROGEN PEROXIDE FUEL COMPOSITIONS SUITABLE FOR USE IN NO OXYGEN ENVIRONMENTS | Kenneth Moden | FELTON, AILEEN BAKER | 1734 | §103§112 | Non-Final OA | — | Pending | Nov 08, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial